Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 2Tongue Neoplasms 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Neutropenia 1Neoplasms 1Lymphedema 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Esthesioneuroblastoma, Olfactory 1Colorectal Neoplasms 1Breast Neoplasms, Male 1Anemia 1

Interventions

pegfilgrastim 16Filgrastim 9Docetaxel 6Cyclophosphamide 6pegylated granulocyte colony-stimulating factor 3eflapegrastim 3liposomal amphotericin B 2Doxorubicin 2Moxibustion 1Methotrexate 1Maxy G34 1MYL-1401H 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Fluorouracil 1Epirubicin 1EC regimen 1Cefepime 1Caspofungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × Moxibustion × Breast × Clear all
NCT02781155 2016-05-24

Limiting Chemotherapy Side Effects by Using Moxa

East and North Hertfordshire NHS Trust

Phase 1/2 Unknown
25 enrolled
BreastClassical hematologyGastrointestinal

Anemia, Breast Neoplasms, Genital Neoplasms, Female, Neoplasms, Neutropenia, Thrombocytopenia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡